Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 213, Issue 10, Pages 1937-1950
Publisher
Rockefeller University Press
Online
2016-09-12
DOI
10.1084/jem.20160792
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of the Hypercitrullination Reaction in Human Neutrophils and Other Leukocytes
- (2015) Yebin Zhou et al. MEDIATORS OF INFLAMMATION
- Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials
- (2015) Daniel Aletaha et al. ARTHRITIS RESEARCH & THERAPY
- The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development
- (2015) A. S. Hartlage et al. Cancer Immunology Research
- Chelation therapy after the Trial to Assess Chelation Therapy
- (2014) Maria D. Avila et al. CURRENT OPINION IN CARDIOLOGY
- Chelation therapy and cardiovascular disease: Connecting scientific silos to benefit cardiac patients
- (2014) Julio G. Peguero et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Rheumatoid Factor as a Potentiator of Anti-Citrullinated Protein Antibody-Mediated Inflammation in Rheumatoid Arthritis
- (2014) Jeremy Sokolove et al. Arthritis & Rheumatology
- Epstein-Barr Virus-Encoded RNAs: Key Molecules in Viral Pathogenesis
- (2014) Dai Iwakiri Cancers
- Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis
- (2013) Jing Shi et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction
- (2013) Gervasio A. Lamas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- EBV-encoded small RNA1 and nonresolving inflammation in rheumatoid arthritis
- (2013) Wen-Chan Chiu et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
- (2013) Josef S Smolen et al. LANCET
- A TACTful reappraisal of chelation therapy in cardiovascular disease
- (2013) Mandeep S. Sidhu et al. Nature Reviews Cardiology
- Immune-Mediated Pore-Forming Pathways Induce Cellular Hypercitrullination and Generate Citrullinated Autoantigens in Rheumatoid Arthritis
- (2013) V. Romero et al. Science Translational Medicine
- Features of the Synovium of Individuals at Risk of Developing Rheumatoid Arthritis: Implications for Understanding Preclinical Rheumatoid Arthritis
- (2013) M. J. H. de Hair et al. Arthritis & Rheumatology
- Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis
- (2012) Christoph Böhler et al. ANNALS OF THE RHEUMATIC DISEASES
- Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity
- (2012) Daniel Aletaha et al. ANNALS OF THE RHEUMATIC DISEASES
- Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritis
- (2012) Nikolaus B. Binder et al. ARTHRITIS AND RHEUMATISM
- EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment
- (2012) Tammy Born et al. TOXICOLOGY MECHANISMS AND METHODS
- Therapeutic blockade of TNF in patients with SLE—Promising or crazy?
- (2011) Martin Aringer et al. AUTOIMMUNITY REVIEWS
- Metal chelation therapy in rheumathoid arthritis: a case report
- (2011) Fabrizia Bamonti et al. BIOMETALS
- Inhibiting the C5–C5a receptor axis
- (2011) Trent M. Woodruff et al. MOLECULAR IMMUNOLOGY
- Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage
- (2011) J. Shi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nonresolving Inflammation
- (2010) Carl Nathan et al. CELL
- Antibodies against cyclic citrullinated peptides in infectious diseases—a systematic review
- (2010) Isabella Lima et al. CLINICAL RHEUMATOLOGY
- Epstein–Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment
- (2010) Mattias Magnusson et al. RHEUMATOLOGY
- Anticyclic citrullinated peptide autoantibodies in systemic lupus erythematosus
- (2010) Usha Singh et al. RHEUMATOLOGY INTERNATIONAL
- Does damage cause inflammation? Revisiting the link between joint damage and inflammation
- (2009) J S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways
- (2009) L. A. Trouw et al. ARTHRITIS AND RHEUMATISM
- Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis
- (2009) Natalia Wegner et al. IMMUNOLOGICAL REVIEWS
- Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis
- (2009) Hüseyin Uysal et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Therapeutic potential of complement modulation
- (2009) Eric Wagner et al. NATURE REVIEWS DRUG DISCOVERY
- Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis
- (2008) Andrew Kinloch et al. ARTHRITIS AND RHEUMATISM
- Autoantibodies to tumor-associated antigens: reporters from the immune system
- (2008) Eng M. Tan et al. IMMUNOLOGICAL REVIEWS
- FDA Report: Eculizumab (Soliris(R)) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria
- (2008) A. Dmytrijuk et al. ONCOLOGIST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More